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The cross-sectional area of the upper airway is known to be lung volume dependent. If, and to what extent, lung
volume variables correlate to nocturnal obstructive apnoeas and oxygen desaturations independently of other
factors known to aect lung volumes and sleep disordered breathing is still unclear.
A total of 92 subjects were examined by ambulatory recording of nocturnal obstructive apnoeas and
desaturations. Sixty-nine of the subjects had a history of snoring and 23 were healthy subjects without complaints
of snoring and daytime sleepiness. All subjects performed static and dynamic spirometry for measurements of lung
volumes. To evaluate the correlation between lung volume variables and apnoea index (AI) and oxygen
desaturation index (ODI), simple and multiple regression analysis was performed.
Expiratory reserve volume (ERV) was found to be lower in subjects with snoring and apnoeas (ERV=10 l) than
in non-snoring subjects (ERV= 17 l), (P50001). Forced expiratory volume in 1 sec (FEV1)/vital capacity (VC)
was slightly, but significantly (P=0031), lower in subjects with snoring and nocturnal apnoeas and desaturations.
In the multiple regression analysis ERV was found to be independently correlated to both AI (R2=013; P=0001)
and ODI (R2=011; P=0002). Multiple regression analysis also revealed that ERV, body mass index (BMI) and
habitual smoking together accounted for 43% of the variation in AI and 48% of the variation in ODI.
We find a significant independent association between ERV and nocturnal obstructive apnoea and oxygen
desaturation frequency. Our results indicate that ERV is correlated to these events to a similar extent, as is obesity.
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Today snoring and obstructive sleep apnoea (OSA) is
recognized as a relatively common disease among men and
women (1,2). In spite of the attention that has been paid to
the disease in recent decades, there is still a great deal of
uncertainty about the pathophysiological mechanisms that
cause the upper airway to collapse.
It has been shown that the cross-sectional area of the
pharynx is lung volume dependent (3,4) and previous
studies have also implicated an association between a
reduced or low lung volume and nocturnal obstructive
apnoeas and desaturations (5,6,7,8). However, obesity is a
common feature in patients with OSA (9) and obesity is
also known to alter lung function, preferably by a reductionReceived 3 May 1999 and accepted in revised form 26 October
1999.
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0954-6111/00/030233+07 $35?00/0in expiratory reserve volume (ERV) and functional residual
capacity (FRC) (10,11). If, and to what extent, lung volume
variables correlate to nocturnal obstructive apnoeas and
oxygen desaturations independently of other factors known
to aect lung volumes and sleep disordered breathing is still
unclear.
The aim of the present study was to evaluate the
association between lung volume variables, measured
during wakefulness, and nocturnal obstructive apnoea
and desaturation frequency.
Population and methods
POPULATION
The study population consisted of the same 103 subjects as
described in a previous publication (12). Subjects with a
history of asthma or other lung disease (n=11) were
excluded from the present investigation. The remaining
population consisted of 69 subjects referred to the clinic for
an investigation of snoring and of 23 healthy non-snoring# 2000 HARCOURT PUBLISHERS LTD
234 J. APPELBERG ET AL.control subjects. The subjects were 68 men, aged 27–70
years (mean 47), and 24 women, aged 37–67 years (mean
53).
The non-snoring subjects were randomly selected from
the local municipality population register. Initially, a total
of 400 subjects were asked by letter if they had any
problems with snoring and/or daytime sleepiness and if they
would be positive to participate in the study. Answers were
received from 346 subjects (865%). Eighty-four subjects
(21%) denied problems of snoring and daytime sleepiness
and were also willing to take part in the investigation. From
this group 33 randomly selected subjects underwent a
nocturnal apnoea and saturation screening investigation.
Twenty-three subjects were without a history of lung
disease and had an AI and ODI of less than 5 and were
finally included into the study. The study protocol was
examined and approved on by the local ethics committee.
ANTHROPOMETRY AND NIGHT
RECORDING
The height and weight of all subjects was measured. With
regard to the history of smoking the subjects were classified
as never smoked, ex-smokers (stopped smoking a year or
more ago) and habitual smokers.
As described previously (12), the subjects underwent a
nocturnal registration of apnoeas and desaturations during
one night in their homes, using a validated unattended
recording device, MicroDigitrapper-S (M-S), Synectics
Medical, Stockholm, Sweden (13). The following registered
parameters were analysed to detect nocturnal obstructive
breathing and obstructive apnoeas: oronasal flow (thermis-
tor), chest movement (mattress — with a polyvinylden-
fluoride motion sensor), abdominal respiration movement
(piezoelectric belt positioned at the level of the diaphragm).
Arterial oxygen saturation was measured by a finger pulse
oximeter. Analysis of the recordings was performed using
an analysis program — Multigram SA (TM, Synectics
Soft., Stockholm, Sweden & Dallas, U.S.A.) software
package. Each recording was examined visually by one
person and apnoeas and oxygen desaturations were rated
manually. By definition, an apnoea was scored when
airflow ceased in the nose and mouth for at least 10 sec
(14) and a desaturation was defined as a drop in saturation
level of 4% or more from the previous baseline (15). A
desaturation that occurred without a preceding apnoea was
interpreted as being caused by a hypopnoea rather than
being a false positive desaturation (15). Both the apnoea
index (AI=number of apnoeas h71) and oxygen desatura-
tion index (ODI=number of 4% desaturations h71) were
calculated on the basis of total time in bed.
SPIROMETRY
Static and dynamic spirometry was performed using a body
plethysmograph (SensorMedics Autobox DL 6200). Vital
capacity (VC), forced vital capacity in 1 sec (FEV1),
functional residual capacity (FRC) and airway resistance
(RAW) were measured. Expiratory reserve volume (ERV),residual capacity (RV) and total lung capacity (TLC) were
calculated. Measurements and calculations of lung volumes
were performed in accordance to standard criteria’s (16,17).
STATISTICAL ANALYSIS
When group comparisons were performed, the Mann–
Whitney U-test was used. Correlation coecients were
computed using Spearman’s rank correlation coecient.
Multiple regression analysis was performed with AI and
ODI as dependent variables. Since the distributions of both
AI and ODI were positively skewed, log transformation of
these variables was performed before the analysis. More-
over, some of the dependent variables were transformed to
make a linear model applicable. We also performed an
analysis to find factors correlating to the lowest saturation
value measured during the nocturnal registration
(SaO2%min). In this analysis, the SaO2%min was set as the
dependent value and factors known to influence this
variable were used as explanatory variables.
Stepwise regression analysis was used as the variable
selection strategy. The set of dependent variables were: age,
sex, smoking factor, BMI, weight, height, FEV1, FEV1/VC,
VC, TLC, RV, RV/TLC, FRC, ERV and RAW. The
smoking factor was defined as: 0=never smoked and ex-
smoker; 1=habitual smoker. Regression diagnostics was
performed by analysing residuals and the influence of
outliers. In all analyses, a P-value equal to or less than 005
was considered statistically significant.
Results
Nocturnal apnoea and desaturation registration showed
that among subjects with a history of snoring 23 subjects
had an AI and ODI of 55, 15 subjects had an AI 55 and
an ODI of 5 and finally 31 subjects had both AI and ODI
of 5.
COMPARISON OF DATA
Overall data for the subjects are displayed in Table 1. As
expected, patients with a history of snoring were more
obese than subjects in the non-snoring group. Expiratory
reserve volume (ERV) as well as the FEV1/VC value was
significantly lower (P50001 and P=0031 respectively) in
the group with snorers and OSA patients.
CORRELATION ANALYSIS
Both weight and BMI were significantly correlated to
AI and ODI (Table 2). Among the lung volume variables
received from the spirometry, ERV, FRC, FEV1/VC and
RAW were all found to be significantly correlated to AI
while a significant correlation to ODI were found for
ERV and FRC (Table 2). Regarding lung volumes, FRC,
ERV and RAW values were significantly correlated to
SaO2%min.
TABLE 1. Night recording, anthropometric and spirometric data
Non-snorers (n=23) Snorers (n=69)
Mean (SD) Range Mean (SD) Range P-value*
Anthropometric data
Sex (M/F) 14/9 — 51/15 — —
Smoke (N/E/H) 13/6/3 — 21/21/25 — —
Age (y) 497 (108) 32–68 482 (92) 27–70 n.s.
Height (cm) 1746 (77) 164–194 1751 (85) 154–190 n.s.
Weight (kg) 777 (125) 59–124 910 (180) 645–150 50001
BMI (kg m72) 258 (37) 200–367 298 (65) 212–586 0002
Night recording data
Total time in bed (h) 70 (20) 11–123 68 (14) 42–124 n.s.
AI (apnoeas h71) 03 (08) 0–3 157 (234) 0–111 50001
ODI (desaturations h71) 14 (12) 0–3 252 (276) 0–106 50001
Max. apnoea length (sec) 86 (130) 0–47 336 (255) 0–114 50001
SaO2%min (%) 884 (28) 84–93 788 (105) 50–94 50001
Spirometric data
FEV1 (l) 36 (08) 23–51 35 (08) 19–54 n.s.
VC (l) 45 (09) 32–63 46 (10) 26–67 n.s.
FEV1/VC 792 (63) 639–894 751 (74) 552–861 0031
FRC (l) 31 (11) 11–48 31 (08) 13–52 n.s.
ERV (l) 17 (06) 05–29 10 (06) 004–27 50001
RV (l) 18 (04) 12–27 21 (06) 08–32 n.s.
TLC (l) 66 (13) 46–90 67 (12) 38 (93) n.s.
RV/TLC 309 (81) 187–593 313 (64) 194–459 n.s.
RAW (kPa71 sec71) 0141 (0076) 005–0370 0145 (0067) 001–0400 n.s.
AI: apnoea index; ODI: oxygen desaturation index; N: never smoked; E: ex-smoker; H: habitual smoker; BMI: body mass
index; VC: vital capacity; FEV1: forced expiratory volume in 1 sec; FRC: functional residual capacity; ERV: expiratory
reserve volume; RV: residual volume; TLC: total lung capacity; RAW: airway resistance; Values represent the mean value and
the standard deviation (SD). *Mann–Whitney U-test.
TABLE 2. Univariate relationship between apnoea index (AI), nocturnal oxygen desaturation index (ODI), SaO2%min and
anthropometric and spirometric variables [values represent the correlation coecient, r and the P-value (P)]
AI ODI SaO2%min
Age 013 (n.s.) 005 (n.s.) 7015 (n.s.)
Height (cm) 7007 (n.s.) 7009 (n.s.) 019 (n.s.)
Weight (kg) 053 (50001) 058 (50001) 7051 (50001)
BMI (kg m72) 052 (50001) 063 (50001) 7060 (50001)
FEV1 (l) 7010 (n.s.) 7011 (n.s.) 020 (n.s.)
VC (l) 7006 (n.s.) 7009 (n.s.) 019 (n.s.)
FEV1/VC 7024 (0025) 7015 (n.s.) 020 (n.s.)
FRC (l) 7023 (0030) 7035 (0001) 039 (50001)
ERV (l) 7055 (50001) 7055 (0001) 060 (50001)
RV (l) 013 (n.s.) 014 (n.s.) 7011 (n.s.)
TLC (l) 7002 (n.s.) 7010 (n.s.) 017 (n.s.)
RV/TLC 014 (n.s.) 030 (n.s.) 006 (n.s.)
RAW (kPa71 sec71) 022 (0046) 019 (n.s.) 026 (0016)
For a definition of abbreviations, see Table 1.
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FIG. 1. The diagram shows the influence of expiratory
reserve volume (ERV, l) on the apnoea index (AI) in a
non-obese (BMI=26) non-smoking subject (continuous
line), a non-obese (BMI=26) smoking subject (dotted-
dashed line), an obese (BMI=35) non-smoking subject
(dashed line) and an obese (BMI=35) smoking subject
(dotted line).
FIG. 2. The diagram shows the influence of expiratory
reserve volume (ERV, l) on the oxygen desaturation index
(ODI) in a non-obese (BMI=26) non-smoking subject
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In the multiple regression analysis, ERV remained as an
independent significant predictor of AI and ODI (Table 3).
When it came to obesity variables, BMI also remained as an
independent predictor of these dependent variables as was
habitual smoking. Analysis revealed that these three
variables together accounted for 43% of the variation in
AI and 48% of the variation in ODI. We included weight
instead of BMI in the equation and found that the partial
correlation coecient between ERV and AI increased
somewhat (R2=022; P50001), as did the partial correla-
tion coecient for ERV and ODI (R2=022; P50001). In
the multiple regression analysis with SaO2%min as the
dependent value, as much as 75% of the variation was
explained by four independent variables, maximum apnoea
length (R2=049; P50001), BMI (R2=019; P=0001),
ERV (R2=006; P=0032) and TLC (R2=0035;
P=0035).
Using the equations from the regression models
(AI=Exp[7711671468*Sqrt[ERV] 2732*Log[BMI]+
0576*Habitual smoking] and ODI=Exp[7920971.285
*Sqrt[ERV]3501*Log[BMI]0576*Habitual smoking]),
we exemplify the eect of the dierent predictors on AI and
ODI in Figs 1 and 2. The figures graphically display the
independent correlation between ERV and AI and ODI.
For two persons with the same BMI and the same smoking
status (habitual smoker or never smoked/ex-smoker), the
model shows that the expected number of apnoeas and
desaturations is higher for a person with a low ERV. It can
also be seen that a decrease in ERV of 1 l at a normal ERV
level results in a lower increase in AI and ODI than a
decrease in ERV at an already low level.
Discussion
The present study, carried out on a large number of subjects
with and without snoring and data compatible with
obstructive sleep apnoea, presents results of a significant
association between expiratory reserve volume (ERV) and
the frequency of nocturnal obstructive apnoeas (AI) and
oxygen desaturations (ODI). We have also shown that thisTABLE 3. Variables which were independently related to the
apnoea index (AI) and oxygen desaturation index (ODI)
AI ODI
R2= 043 R2=048
ERV (l) R2=013
P=0001
R2=011
P= 0002
BMI (kg m72) R2=010
P=0003
R2=017
P50001
Habitual
smoking
R2=006
P=0028
R2=006
P=0021
For a definition of abbreviations, see Table 1.
(continuous line), a non-obese (BMI=26) smoking
subject (dotted-dashed line), an obese (BMI=35) non-
smoking subject (dashed line) and an obese (BMI=35)
smoking subject (dotted line).association is present after adjusting for other factors
known to aect sleep disordered breathing, such as obesity
and habitual smoking, as well as factors known to aect
lung volume itself. ERV was also found to correlate
independently, although to a lesser extent, to the lowest
nocturnal SaO2%min. These results are interesting since
they indicate that the predictive value of a low ERV is
similar to that of obesity in predicting nocturnal apnoeas
and desaturations.
LUNG VOLUME IN SUBJECTS WITH SNORING AND OSA 237Previous reports have suggested that the cross-sectional
area of the upper airway is lung volume dependent, a
phenomenon most pronounced in patients with OSA (3,4)
and at low lung volume. The change in cross-sectional area
following a decrease in lung volume has also been reported
to independently correlate to the apnoea/hypopnoea index
(AHI) (18). O¨nal et al. (5) reported that functional residual
capacity (FRC) and inspiratory airway conductance
(GAW) were correlated to AHI in a group of 34 patients
with OSA. In our study, RAW displayed a significant
correlation to AI but did not remain as an independent
predictor in the multivariate analysis. This could be
explained by the fact that RAW has been shown to increase
when lung volume decreases (19).
The physiological mechanisms explaining the correlation
between low lung volume and upper airway closure during
sleep are not fully understood. It is, however, probable that
dierent reflex mechanisms are involved. When lung
volume decreases, a more negative inspiratory pressure is
seen (20). Normally, the activity of both the laryngeal
muscles and the diaphragm increase when negative
inspiratory pressure increases (21). However, the activity
of the genioglossus muscle is insucient to compensate for
negative pressure at the onset of upper airway occlusion in
obese patients with OSA, ‘the balance of pressures concept’
(22). In addition, subjects with OSA have an impaired
capability to increase respiratory muscle drive during
increased mass loading compared with equally obese
subjects without OSA (23).
Our results, which indicate that ERV and not FRC is
independently correlated to ODI and the lowest nocturnal
SaO2%, are in agreement with the results presented by
Se´rie`s et al. (6). They reported that the fall in SaO2% in
subjects with OSA is highly correlated to lung volume, a
phenomenon also seen in the healthy subject (24). The
hypothesis of low lung volume as a determinant of
nocturnal hypoxemia in subjects with OSA is also supported
in a report by Bradley et al. (8), which shows that expiratory
reserve volume is strongly correlated to nocturnal mean
SaO2%. The physiological mechanism may be that there is
an increase in the closure of peripheral airways, especially in
the lower dependent regions of the lung (25). Our results
also show that the length of the apnoea is a determining
factor for the lowest nocturnal SaO2%.
We found obesity to be an independent predictor of both
AI and ODI, a correlation that is well known (26,27,28,29).
In addition, smoking has been suggested as a risk factor for
OSA (30), possibly since smoke could cause oedema and
inflammation in the tissue in the upper airway and thus
have a negative eect on cross-sectional area (31). In our
study, a weak but significant correlation between habitual
smoking and AI and ODI was found.
We chose to study actual lung volume variables and not
the variables expressed as a percentage of a predicted
normal value. Obesity is known to aect lung volume
(10,11) and the possibility of lung volume related co-
founders influencing our results was therefore taken into
account in the multiple regression analysis where adjust-
ments were made for both weight and BMI. In addition,
other factors known to influence lung volume such as age,height, smoking and sex were also taken into account in the
multiple regression analysis.
Chronic obstructive pulmonary disease has been shown
to co-exist in some patients with OSA (32,33). It has also
been suggested that asthma may be associated with
increased daytime sleepiness (34), the latter also being a
symptom of OSA. In order to reduce the possibility of bias
due to these factors, no subject with a history of any lung
disease was included in the study. In addition we made
adjustments for variables known to describe airway
obstruction such as FEV1, FEV1/VC, RV/TLC and RAW
in the multiple regression analysis. In our group of subjects,
FEV1/VC and RAW were correlated to AI, but these
variables did not remain as independent predictors in the
multivariate analyses. Smoking is well known to aect the
lungs and the airways and thus also lung function variables
such as FEV1 and VC. Thus the dierence in FEV1/VC
found between non-snorers and snorers could be secondary
due to the dierences in the ratio of habitual smokers/non-
smoker between the two groups. The smoking factor could
also be one possible cause as to why we did not find an
independent association between airway obstruction and
AI/ODI. Others (34,35,36) have described a correlation
between airway obstruction and sleep apnoea severity.
However, the fact that ERV and not FRC were
independently correlated to AI/ODI may reflect the
presence of diuse airway obstruction. As mentioned
earlier, Bradley et al. (8) found that ERV was an
independent predictor of nocturnal mean SaO2% while
FRC was not. In that report it was discussed and concluded
that this could be due to a combination of obesity and
diuse airway obstruction. ERV may be aected in two
ways. First obesity may eect ERV by decreasing FRC.
Secondly, ERV may be decreased by an increase in residual
volume (RV) caused by increase in airway closure.
Especially in obesity the reduction in ERV may be
associated with closure of small peripheral airways (37).
A limitation with the present study is that sleep was not
registered and this should be kept in mind when interpret-
ing the significance of our results. Thus, both AI and ODI
may have been underestimated since calculations of indices
were made on total time in bed and not on total sleep time.
Since lung volume is reduced both by supine position and
by sleep it should also be stated that in the present study,
lung volume was measured during wakefulness and in the
sitting position.
In conclusion, we find a significant correlation between
ERV and both nocturnal apnoea and desaturation fre-
quency. This correlation is still present after adjusting for
confounding factors such as obesity and smoking. Our
results indicate that ERV is associated with nocturnal
apnoeas and desaturations to a similar extent, as is obesity.
Our results could indicate that increased airway resistance
contributes to nocturnal apnoea and desaturation frequency.
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